(Q46793862)

25 December 2017

title

Steady-State Pharmacokinetics of Nevirapine in HIV-1 Infected Adults in India (English)

1 reference

25 December 2017

1 reference

1 reference

1 reference

9

Soumya Swaminathan

1 reference

25 December 2017

Geetha Ramachandran

1

1 reference

25 December 2017

A K Hemanthkumar

2

1 reference

25 December 2017

S Rajasekaran

3

1 reference

25 December 2017

C Padmapriyadarsini

4

1 reference

25 December 2017

G Narendran

5

1 reference

25 December 2017

S Anitha

6

1 reference

25 December 2017

Sudha Subramanyam

7

1 reference

25 December 2017

V Kumaraswami

8

1 reference

25 December 2017

publication date

1 December 2007

1 reference

25 December 2017

Journal of the International Association of Providers of AIDS Care

published in

1 reference

25 December 2017

volume

6

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

251-254

1 reference

25 December 2017

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301344

Effectiveness of generic fixed-dose combinations of highly active antiretroviral therapy for treatment of HIV infection in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301344

Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301344

Therapeutic Drug Monitoring of the HIV/AIDS Drugs Abacavir, Zidovudine, Efavirenz, Nevirapine, Indinavir, Lopinavir, and Nelfinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301344

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301344

The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301344

Stable concentrations of zidovudine, stavudine, lamivudine, abacavir, and nevirapine in serum and cerebrospinal fluid during 2 years of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301344

Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301344

Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301344

Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109707301344

21 January 2018

Identifiers

DOI

10.1177/1545109707301344

1 reference

25 December 2017

1 reference

25 December 2017